Literature DB >> 16890317

Radiation-induced effects on gene expression: an in vivo study on breast cancer.

Aslaug Helland1, Hilde Johnsen, Caroline Frøyland, Hege B K Landmark, Anna B Saetersdal, Marit Muri Holmen, Turid Gjertsen, Jahn M Nesland, William Ottestad, Stefanie S Jeffrey, Lars O Ottestad, Olag K Rodningen, Gavin Sherlock, Anne-Lise Børresen-Dale.   

Abstract

BACKGROUND AND
PURPOSE: Breast cancer is diagnosed worldwide in approximately one million women annually and radiation therapy is an integral part of treatment. The purpose of this study was to investigate the molecular basis underlying response to radiotherapy in breast cancer tissue.
MATERIAL AND METHODS: Tumour biopsies were sampled before radiation and after 10 treatments (of 2 Gray (Gy) each) from 19 patients with breast cancer receiving radiation therapy. Gene expression microarray analyses were performed to identify in vivo radiation-responsive genes in tumours from patients diagnosed with breast cancer. The mutation status of the TP53 gene was determined by using direct sequencing. RESULTS AND
CONCLUSION: Several genes involved in cell cycle regulation and DNA repair were found to be significantly induced by radiation treatment. Mutations were found in the TP53 gene in 39% of the tumours and the gene expression profiles observed seemed to be influenced by the TP53 mutation status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890317     DOI: 10.1016/j.radonc.2006.07.007

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

1.  FAS Death Receptor: A Breast Cancer Subtype-Specific Radiation Response Biomarker and Potential Therapeutic Target.

Authors:  Janet K Horton; Sharareh Siamakpour-Reihani; Chen-Ting Lee; Ying Zhou; Wei Chen; Joseph Geradts; Diane R Fels; Peter Hoang; Kathleen A Ashcraft; Jeff Groth; Hsiu-Ni Kung; Mark W Dewhirst; Jen-Tsan A Chi
Journal:  Radiat Res       Date:  2015-10-21       Impact factor: 2.841

2.  Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors.

Authors:  Mark Kidd; Irvin M Modlin; Ignat Drozdov
Journal:  BMC Genomics       Date:  2014-07-15       Impact factor: 3.969

3.  Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy.

Authors:  Ann Rita Halvorsen; Aslaug Helland; Thomas Fleischer; Karen Marie Haug; Grethe Irene Grenaker Alnaes; Daniel Nebdal; Randi G Syljuåsen; Nizar Touleimat; Florence Busato; Jörg Tost; Anna B Saetersdal; Anne-Lise Børresen-Dale; Vessela Kristensen; Hege Edvardsen
Journal:  Int J Cancer       Date:  2014-04-05       Impact factor: 7.396

4.  Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.

Authors:  L Fabris; S Berton; F Citron; S D'Andrea; I Segatto; M S Nicoloso; S Massarut; J Armenia; G Zafarana; S Rossi; C Ivan; T Perin; J S Vaidya; M Avanzo; M Roncadin; M Schiappacassi; R G Bristow; G Calin; G Baldassarre; B Belletti
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.